The Pain Factor

Written by Louise Roach


The Pain Factor

Last year I told an acquaintance that atrepparttar age of 46, I had taken up running. The reply was, “Oh, that’s awfully hard on your knees.” At first I was taken aback. Yes, I knew if I didn’t stretch, warm-up or wear properly fitted shoes, I might experience pain or an injury. Butrepparttar 115253 person telling me this was overweight, had borderline high blood pressure, and never worked out. I wondered if this friend realized by living a sedentary lifestyle,repparttar 115254 odds of developing heart disease, osteoporosis, diabetes and some cancers had substantially increased. Not to mention that being overweight actually placed this person at a higher risk than me for developing knee pain from osteoarthritis and heel pain as a result of plantar fasciitis. I’m no spring chicken and sometimes my running resembles a dawdling old hen. But I do know it’s necessary to take precautions at any age to guard against injury when participating in physical activity such as running. Becauserepparttar 115255 truth is, sometimes pain happens. When it does, you can either use pain as an excuse or you can use it as a diagnostic tool to help improve and go forward with your performance. There are three classifications of pain. In simple terms, these can be described asrepparttar 115256 following:

Nociceptive Pain: felt after an injury to body tissues such as cuts, sprains, broken bones, bruising, surgery, and sometimes cancer. Most pain is of this type.

Neuropathic Pain: resulting from an injury to nerves,repparttar 115257 spinal cord orrepparttar 115258 brain, examples being Phantom Limb Pain and shingles – which affects nerve tissue.

Psychogenic Pain: is related to a psychological disorder whererepparttar 115259 type, intensity or proportion of pain experienced is greater thanrepparttar 115260 injury. Some chronic ailments may be related to this type of pain.

Pain can also be defined as acute (an immediate response to an injury) or chronic (a pain lasting more than six weeks). The majority of injuries from physical activity fall intorepparttar 115261 category of acute nociceptive pain. Although some overuse injuries such as Plantar Fasciitis or Runner’s Knee can become chronic if not properly treated or allowed enough time to heal. Most injuries to body tissues are minor and can be treated with nonsteroidal antiinflammatory drugs (NSAID), such as ibuprofen, and ice therapy or R.I.C.E. (rest, ice, compression and elevation) to decrease pain. Cuts, bruises, strains, sprains, swelling and inflammation can generally be treated in this way. Severe acute injuries, such as fractured bones and ruptured tendons, should always be treated by a medical professional, as isrepparttar 115262 case with injuries resulting in chronic, neuropathic and psychogenic pain. If you experience minor pain or inflammation during an activity, this is a good time to evaluate what your body is saying and respond in a positive, strengthening manner. Try askingrepparttar 115263 following questions: 1. What particular part of my body is affected? 2. Doesrepparttar 115264 pain happen only during a certain activity or is it constant? 3. Am I experiencing pain when running or walking on a certain type of terrain? 4. Is this a new pain or one that has happened before? 5. What measures can I take to correct or strengthenrepparttar 115265 affected body area?

New Cancer Treatment Promises Hope

Written by C. Bailey-Lloyd/Lady Camelot


New Cancer Treatment Promises Hope by C. Bailey-Lloyd

Intraperitoneal Hyperthermic Chemotherapy (IPHC) with Mitomycin C after Cytoreductive Surgery for Patients with Peritoneal Carcinomatosis - a long, technical term for modern medicine inrepparttar fight against cancer.

I hadrepparttar 115252 rare opportunity to speak with Dr. Perry Shen of Wake Forest University. As I listened, he explained how this groundbreaking treatment is extendingrepparttar 115253 lives of patients suffering from Peritoneal Carcinomatosis. *(Peritoneal membrane surrounds and lubricatesrepparttar 115254 surface of organs withinrepparttar 115255 abdomen; eg., colon, gallbladder, spleen, ovaries, intestines, liver, etc..) Because Advanced-stage Peritoneal carcinomatosis (cancer) and disseminated peritoneal lymphomas are often resistant to current chemotherapy treatment, medical researchers out of Wake Forest University have engaged inrepparttar 115256 study and treatment of peritoneal carcinomatosis since 1991.

Dr. John Spratt first began describing using interdominal heated therapy in 1980, and found that this particular method worked well in conjunction with chemotherapy. By giving chemotherapy interdominally with much higher concentrated heat, (41 degrees Celcius - or around 105 degrees Fahrenheit) through tumor-removal surgery,repparttar 115257 heated medicine showed an increase in its effectiveness; thus, decreasing tumors. (1. Cytoreductive surgery consists ofrepparttar 115258 removal of all gross tumors and involved organs, peritoneum, or tissue deemed technically feasible and safe forrepparttar 115259 patient. Any tumors adherent or invasive to vital structures that could not be removes were cytoreduces usingrepparttar 115260 cavitational ultrasonic surgical aspirator.)

Overall survival rates were improved of 109 Patients (with peritoneal carcinomatosis) treated between December 1991 and November 1997. (2. Clinicopathologic factors that independently predicted improved overall survival rates.)

A one-time treatment, IHPC lasts approximately 1-2 hours, but standardly, a 2-hour treatment is utilized by Wake Forest University. Initially, patients are cooled to a core temperature of approximately 34?C to 35?C. Once cooled, peritoneal perfusion inflow and outflow catheters are placed peroutaneously intorepparttar 115261 abdominal cavity. With temperature probes acting as moderators,repparttar 115262 abdomen is gently massaged throughout perfusion to enhance drug distribution to all peritoneal areas. Because tumor tissue is more responsive to heat than normal tissue (due to intrinsic thermosensitivity) IHPC improvesrepparttar 115263 chemosensitivity of tumor cells to Mytomycin C(MMC).

With an average life expectancy of 3-6 months after diagnosis of Peritoneal Carcinomatosis, patients are gaining new hope as IHPC treatment is extending life by as much as 15 months; and a few selected patients' lives have even been extended to 28-30 months.

Cont'd on page 2 ==>
 
ImproveHomeLife.com © 2005
Terms of Use